![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Springe zu: 2016
Anzahl der Publikationen: 4
2016
Thiel, U.; Blaeschke, F.; Richter, G. und Burdach, S.
(2016):
Human HLA-A*02:01/CHM1+allo-restricted T cell receptor-transgenic CD8+T cells specifically inhibit Ewing sarcoma growth in vitro and in vivo.
In: European Journal of Cancer, Bd. 69:
S51-S51
Schirmer, D.; Grünewald, T.; Klar, R.; Schmidt, O.; Wohlleber, D.; Alba Rubío, R.; Uckert, W.; Thiel, U.; Protzer, U.; Busch, D.; Krackhardt, A.; Burdach, S. und Richter, G.
(2016):
Transgenic antigen-specific, HLA-A*02:01-allo-restricted cytotoxic T cells recognize and kill tumor associated antigen STEAP1+tumour cells in vivo.
In: European Journal of Cancer, Bd. 69:
S93-S93
Thiel, U.; Blaeschke, F.; Richter, G.; Grünewald, T.; Busch, D.; Alba Rubio, R.; Thiede, M.; Kirschner, A.; Pirson, S.; Mall, S.; Klar, R.; Leisegang, M.; Krackhardt, A.; Uckert, W.; Riddell, S. und Burdach, S.
(2016):
Human T Cell Receptor transgenic CD8(+) T cells specifically kill HLA-A*0201/CHM1(+) Ewing Sarcoma Lines in vitro and in a preclinical Mouse Model.
In: Oncology Research and Treatment, Bd. 39: S. 147
Thiel, U.; Teichert von Luettichau, L.; Wawer, A.; Bender, H.-U.; Blaeschke, F.; Grünewaid, T.; Steinborn, M.; Bader, P.; Röper, B.; Bönig, H.; Klingebiel, T.; Koscielniak, E.; Dirksen, U.; Juergens, H.; Kolb, H. und Burdach, S.
(2016):
Stem cell rescue after irradiation of multiple tumor sites combined with high-dose chemotherapy - high long-term survival in patients with advanced translocation positive pediatric sarcomas without bone marrow involvement.
In: Oncology Research and Treatment, Bd. 39: S. 39